Portfolio map · VC firm · South Korea
Partners Investment portfolio map
21 startups Partners Investment has backed in rounds we track, since 2020, grouped by their main sector. Together they have raised $1.0B. The biggest sector is Biotech, with 11 companies.
Biotech
11
Funding by segment
- Biotech$562M11
- AI$413M7
- Healthtech$62M3
Where they are based
- United States9$659M
- South Korea4$92M
- China1$37M
United States
South Korea
ChinaFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M7
- $10M to $50M6
- $50M to $250M8
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
20 of 21 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- South Korea4
- China1
Startups by country, 3 countries in all.
Segment by segment
Biotech
11 startups · $562M raised
AffaMed TherapeuticsAffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.-$170M
Senda BiosciencesSenda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.United States$123M
Ring TherapeuticsRing Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.United States$87M
AltPepAltPep is a Seattle-based biotechnology company founded in 2018 that focuses on developing early disease-modifying treatments and United States$53M
Adcentrx TherapeuticsAdcentrx Therapeutics is a clinical-stage biotechnology company based in San Diego, California, founded in 2021.United States$51M
Newracle GeneticsNewracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.-$27M- EENCellENCell is a biotech company that develops and manufactures biopharmaceuticals.United States$15M
Pinot BioPinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.-$9.5M
AI
7 startups · $413M raised
Harbinger HealthHarbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.United States$140M
VeritoneVeritone has created a future-proof AI platform that comprehends and transforms multiple forms of data to create actionable intelligence.United States$140M
BOS SemiconductorsBOS Semiconductors is a global fabless semiconductor company based in Seongnam-si, South Korea, founded in May 2022.South Korea$65M
Phantom AIPhantom AI creates and delivers an advanced computer vision and related ADAS technology to automotive OEMs and Tier 1s.United States$42M
MedipixelMedipixel, Inc.South Korea$13M
XBoostXBoost develops AI agents for online marketplace sellers and brands to automate their growth and operations with breakthrough innovation.United States$8.6M
ArtbloodArtblood is a cell-based artificial blood production company.South Korea$4.8M
Healthtech
3 startups · $62M raised
GeneCastGeneCast provides cancer screening, monitoring, precision care services.China$37M
Cenyx BiotechCenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.-$17M- DBDime BioDime Bio is a drug development company for novel dementia treatments.-$8.2M
How this map is made. Every startup here has raised money in a round we track that names Partners Investment as an investor, the first in 2020. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Partners Investment?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.